Artemis Global Life Sciences Ltd. - (Amalgamated) - Stock Valuation and Financial Performance

BSE: 540616 | NSE: AGLSL | Steel/Sponge Iron/Pig Iron | Small Cap

Artemis Global-Amalg Share Price

51 0.00 0.00%
as on 22-Oct'19 18:59

DeciZen - make an informed investing decision on Artemis Global-Amalg

M-Cap below 100cr DeciZen not available

Artemis Global Life Sciences Ltd. - (Amalgamated) stock performance -

mw4me loader
P/E Ratio (SA):
0.00
Market Cap:
327.3 Cr.
52-wk low:
51
52-wk high:
58

Is an attractive stock to invest in?

1. Is a good quality company?

Data is not available for this company.

2. Is undervalued or overvalued?

The key valuation ratios of Artemis Global Life Sciences Ltd. - (Amalgamated)'s currently when compared to its past seem to suggest it is in the Overvalued zone.

3. Is a good buy now?

No data found

10 Year X-Ray of Artemis Global-Amalg:

Analysis of Financial Track Record

Data adjusted to bonus, split, extra-ordinary income, rights issue and change in financial year end
Data adjusted to bonus, split, extra-ordinary income, rights issue and change in financial year end

Data adjusted to bonus, split, extra-ordinary income, rights issue and change in financial year end.

Financial track record gives insight into the company's performance on key parameters over the past ten years. MoneyWorks4me’s proprietary colour codes make it easy for retail investors to gauge the company’s past performance.

Value Creation

Value Creation Index Colour Code Guide

Mar'10Mar'11Mar'12Mar'13Mar'14Mar'15Mar'16Mar'17Mar'18Mar'19TTM
ROCE % 0%-32.7%-65.2%-19.5%-9.9%-11.1%-204.1%0.2%-0.1%-0.1%-
Value Creation
Index
NA-3.3-5.7-2.4-1.7-1.8-15.6-1.0-1.0-1.0-

Growth Parameters

Growth Parameters Colour Code Guide

Sales 00000000.40.40.40
Sales YoY Gr.-NANANANANANANA0%0%-
Adj EPS 0-2.5-3.7-0.8-0.6-0.6-3.50-0-0-0
YoY Gr.-NANANANANANANA-250%NA-
BVPS (₹) 000000002423.923.9
Adj Net
Profit
000000-0.20.2-0.2-0.10
Cash Flow from Ops. 0000000.10.4-0.4-0.1-
Debt/CF from Ops. 0000000000-

CAGR

CAGR Colour Code Guide

9 Years 5 Years 3 Years 1 Years
Sales NANANA0%
Adj EPS NANANANA
BVPSNANANA-0.1%
Share Price - -2.5% - -

Key Financial Parameters

Performance Ratio Colour Code Guide

Mar'10Mar'11Mar'12Mar'13Mar'14Mar'15Mar'16Mar'17Mar'18Mar'19TTM
Return on
Equity %
0-32.7-65.2-19.5-9.9-11.1-204.10.2-0.1-0.1-0.1
Op. Profit
Mgn %
000000087.8-29.6-59.4-64.5
Net Profit
Mgn %
000000036.3-54.4-28.7-48.4
Debt to
Equity
0000000000-
Working Cap
Days
000000035687720
Cash Conv.
Cycle
000000005050-1,421

Recent Performance Summary

No data to display

Return on Equity has declined versus last 3 years average to %

Sales growth has been subdued in last 3 years %

Net Profit has been subdued in last 3 years %

Sales growth is not so good in last 4 quarters at %

Latest Financials - Artemis Global Life Sciences Ltd. - (Amalgamated)

Standalone Consolidated
TTM EPS (₹) -0 3.2
TTM Sales (₹ Cr.) 0.4 556
BVPS (₹.) 23.9 35.1
Reserves (₹ Cr.) 145 219
P/BV 2.07 1.41
PE 0.00 15.51
From the Market
52 Week Low / High (₹) 51.00 / 57.95
All Time Low / High (₹) 42.05 / 159.15
Market Cap (₹ Cr.) 327
Equity (₹ Cr.) 13.2
Face Value (₹) 2
Industry PE 19.7

Management X-Ray of Artemis Global-Amalg:

Shareholding Pattern

Promoter's Holding & Share Pledging

Pledged *0.000.000.000.000.000.000.000.000.000.00
* Pledged shares as % of Promoter's holding (%)

Event Update

Login/Register to view analysis.

Analyst's Notes

Key Ratios of Artemis Global-Amalg

Adj EPS (Rs.)

Sales (Cr.)

ROE (%)

ROCE (%)

Profit And Loss

(All Figures are in Crores.)
PARTICULARSMar'11Mar'12Mar'13Mar'14Mar'15Mar'16Mar'17Mar'18Mar'19
Sales0000000.410.410.41
Operating Expenses 0.010.020.010.010.010.210.050.530.65
Manufacturing Costs000000000
Material Costs000000000
Employee Cost 00000000.150.25
Other Costs 0.010.020.010.010.010.210.050.370.40
Operating Profit -0.01-0.02-0.01-0.01-0.01-0.210.36-0.12-0.24
Operating Profit Margin (%) ------87.8%-29.6%-59.4%
Other Income 000000.36000
Interest 000000000
Depreciation 0000000.150.150.15
Exceptional Items 0000000-0.110
Profit Before Tax -0.01-0.02-0.01-0.01-0.010.140.21-0.38-0.39
Tax 000000.070.06-0.08-0.28
Profit After Tax -0.01-0.02-0.01-0.01-0.010.070.15-0.30-0.12
PAT Margin (%) ------36.3%-73.2%-28.7%
Adjusted EPS (₹)-2.5-3.7-0.8-0.6-0.61.50.0-0.10.0
Dividend Payout Ratio (%)0%0%0%0%0%0%0%0%0%

Balance Sheet

(All Figures are in Crores.)
PARTICULARSMar'11Mar'12Mar'13Mar'14Mar'15Mar'16Mar'17Mar'18Mar'19

Equity and Liabilities

Shareholders Fund 0.040.020.060.060.050.12158.84158.54158.42
Share Capital 0.050.050.100.100.100.1013.2413.2413.24
Reserves -0.01-0.03-0.04-0.04-0.050.02145.60145.30145.18
Minority Interest000000000
Debt000000000
Long Term Debt000000000
Short Term Debt000000000
Trade Payables000000000
Others Liabilities 0.01000.010.010.083.523.383.14
Total Liabilities 0.050.020.070.060.060.20162.35161.91161.56

Fixed Assets

Gross Block0000002.082.082.08
Accumulated Depreciation0000000.160.310.46
Net Fixed Assets0000001.921.771.62
CWIP 000000000
Investments 000.050.050.050159.91159.91159.91
Inventories000000000
Trade Receivables00000000.110
Cash Equivalents 0.050.020.020.010.010.130.520.090
Others Assets000000.070.010.030.03
Total Assets 0.050.020.070.060.060.20162.35161.91161.56

Cash Flow

(All Figures are in Crores.)
PARTICULARSMar'11Mar'12Mar'13Mar'14Mar'15Mar'16Mar'17Mar'18Mar'19
Cash Flow From Operating Activity 0-0.03-0.01-0.0100.070.39-0.43-0.09
PBT -0.01-0.02-0.01-0.01-0.010.140.21-0.38-0.39
Adjustment 0000000.150.150.15
Changes in Working Capital 0.01-0.0100000.04-0.170.16
Tax Paid 00000-0.07-0.01-0.030
Cash Flow From Investing Activity 00-0.05000.05000
Capex 000000000
Net Investments 000000.05000
Others 00-0.05000000
Cash Flow From Financing Activity 0.0500.05000000
Net Proceeds from Shares 0.0500.05000000
Net Proceeds from Borrowing 000000000
Interest Paid 000000000
Dividend Paid 000000000
Others 000000000
Net Cash Flow 0.05-0.03-0.01-0.0100.120.39-0.43-0.09
PARTICULARSMar'11Mar'12Mar'13Mar'14Mar'15Mar'16Mar'17Mar'18Mar'19
Ratios
ROE (%)-32.73-65.17-19.51-9.93-11.1384.580.19-0.19-0.07
ROCE (%)-32.73-65.17-19.51-9.93-11.13166.360.27-0.24-0.25
Asset Turnover Ratio0000000.0100
PAT to CFO Conversion(x)N/AN/AN/AN/AN/A12.6N/AN/A
Working Capital Days
Receivable Days00000001000
Inventory Days000000000
Payable Days000000000

Artemis Global Life Sciences Ltd. - (Amalgamated) Stock News

Artemis Global Life Sciences Ltd. - (Amalgamated) FAQs

Company share prices are keep on changing according to the market conditions. The closing price of Artemis Global-Amalg on 22-Oct-2019 18:59 is ₹51.00.
Market capitalization or market cap is determined by multiplying the current market price of a company's shares with the total number of shares outstanding. As of 22-Oct-2019 18:59 the market cap of Artemis Global-Amalg stood at ₹327.3.
The latest P/E ratio of Artemis Global-Amalg as of 22-Oct-2019 18:59 is 0.00.
The latest P/B ratio of Artemis Global-Amalg as of 22-Oct-2019 18:59 is 2.07.
The 52-week high of Artemis Global-Amalg is ₹57.95 and the 52-week low is ₹51.00.
The TTM revenue is Trailing Twelve Months sales. The TTM revenue/sales of Artemis Global-Amalg is ₹0.41 ( Cr.) .

About Artemis Global Life Sciences Ltd. - (Amalgamated)

No data to display
You have 2 views remaining as a Guest User. To get DeciZen Rating of 3,500+ Stocks based on their Quality, Valuation and Price Trend Login Now
© 2024 The Alchemists Ark Pvt. Ltd. All rights reserved. MoneyWorks4Me ® is a registered trademark of The Alchemists Ark Pvt.Ltd.